Mitiglinide

Mitiglinide is an oral anti-diabetic medication used to treat type 2 diabetes mellitus. It helps control blood sugar levels by stimulating rapid insulin release from the pancreas, especially after meals. Mitiglinide is typically used in combination with other antidiabetic drugs like metformin. It is grouped under the following drug class(es): Hypoglycemics. Its therapeutic use is listed as antidiabetic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include mitiglinida and mitiglinidum. Its PubChem CID is 121891.

CAS No 145375-43-5
Molecular Formula C19H25NO3
Molecular Weight 315.40 g/mol
Synonyms (2S)-4-[(3aS,7aR)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoic acid

Frequently Asked Questions